Pharmacyclics, Inc. (PCYC) Tops Q2 EPS by 33c

February 14, 2013 4:08 PM EST
Get Alerts PCYC Hot Sheet
Trade PCYC Now!
Join SI Premium – FREE
Pharmacyclics, Inc. (NASDAQ: PCYC) reported Q2 EPS of $0.62, $0.33 better than the analyst estimate of $0.29. Revenue for the quarter came in at $57.96 million versus the consensus estimate of $45.74 million.

For earnings history and earnings-related data on Pharmacyclics, Inc. (PCYC) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment